Chubby Brain_Logo

Aegerion Pharmaceuticals Investors Complete a Venture Capital Round of Funding




Warning: Illegal string offset 'keywords_time' in /home/chubbybrain/public_html/blog/wp-content/plugins/internal_link_building.php_/internal_link_building.php on line 103

Aegerion Pharmaceuticals (http://www.aegerion.com) raised a venture capital round of funding. The company is located in Bridgewater, New Jersey.

Aegerion Pharmaceuticals, Inc. is a privately held specialty pharmaceutical company. The company is focused on the development and commercialization of pharmaceuticals to treat cardiovascular and metabolic disease. Its most advanced products are MTP inhibitors which have demonstrated significant clinical effects in Phase II trials in patients with various forms of hyperlipidemia and whose cholesterol levels remain uncontrolled on currently available dyslipidemia therapies. MTP inhibitors represent a potentially new therapeutic approach for hyperlipidemia and a significant commercial opportunity for Aegerion.

This Aegerion Pharmaceuticals funding from was detailed in FundingFlash – a comprehensive daily email detailing companies receiving venture capital, growth equity or angel investment funding.

You can leave a response, or trackback from your own site.

Leave a Reply